The Fentanyl Frontier: Who Is Actually Smuggling the Drugs?

For years, the political rhetoric surrounding the U.S. southern border has linked two distinct issues: the surge in illegal migration and the devastating fentanyl epidemic. A common refrain from conservative commentators and the Trump administration is that illegal immigrants are the primary conduit for the synthetic opioid killing tens of thousands of Americans annually.

However, an analysis of data from U.S. Customs and Border Protection (CBP), the Drug Enforcement Administration (DEA), and independent research organizations reveals a starkly different reality. While the southern border is indeed the primary entry point for fentanyl, the actors and methods involved are rarely the individuals crossing the desert on foot to seek asylum.

Where the Drugs are Found

To understand who is bringing fentanyl into the country, one must first look at where it is being caught. According to CBP data for the 2024 and 2025 fiscal years, approximately 90% of all fentanyl seizures occurred at legal Ports of Entry (POEs) or interior vehicle checkpoints [1]. These are the official crossings where cars, trucks, and pedestrians are processed by Customs officers.

In contrast, the U.S. Border Patrol—which patrols the vast stretches of land between these ports where most illegal crossings occur—accounts for less than 10% of total fentanyl seizures. This disparity is driven by the nature of the drug itself. Fentanyl is extremely potent and compact; a few pounds can be worth millions of dollars and represent thousands of lethal doses, making it far more efficient to hide in a hidden compartment of a passenger vehicle or a commercial truck than to carry it through a rugged, dangerous wilderness on foot.

The "Citizen Smuggler" Phenomenon

Perhaps the most persistent myth in the border debate is the identity of the smugglers. Data from the U.S. Sentencing Commission and analysis by the Cato Institute show that U.S. citizens are the primary actors in the fentanyl trade. Between 2019 and 2024, approximately 80% to 86% of individuals convicted of fentanyl trafficking at the southern border were U.S. citizens [2][3].

The reason for this preference by Mexican cartels, such as the Sinaloa and Jalisco (CJNG) organizations, is tactical. U.S. citizens typically face lower levels of scrutiny at ports of entry, have a guaranteed right of entry, and are less likely to be referred for the intensive secondary inspections that migrants frequently undergo. Cartels view migrants as "low-reward, high-risk" couriers for high-value narcotics, preferring instead to use sophisticated concealment in the millions of vehicles that cross legally every year.

Recent Trends in 2025 and 2026

As of March 2026, the volume of fentanyl being seized at the border has actually begun to decline from its 2023 peak. In Fiscal Year 2025, CBP reported approximately 7,500 lbs of fentanyl seized—a 55% decrease from the previous year [4]. While the administration attributes this to "operational control" and successful interdiction efforts like Operation Plaza Spike, some experts suggest it may reflect a shift in cartel strategy or a saturation of the market.

Despite the decrease in volume, the potency remains a grave concern. The DEA reports that 7 out of 10 fentanyl pills seized in early 2026 contain a potentially lethal dose [5]. This highlights that while the *number* of smugglers caught may be fluctuating, the danger posed by those who succeed remains at historic highs.

The Full Picture

The reality of the fentanyl crisis presents a policy challenge that transcends simple border wall rhetoric. If the majority of the drug is entering through legal ports of entry in vehicles driven by U.S. citizens, then physical barriers between ports do little to stop the flow. Instead, experts suggest that the most effective interventions involve high-tech scanning equipment at ports, better intelligence on cartel logistics, and addressing the domestic demand that fuels the trade.

Furthermore, equating migrants with drug smugglers can have significant public health consequences. When the focus remains on the "migrant threat," resources may be diverted away from the ports of entry where the drugs are actually found. Data shows that fentanyl is seized in fewer than 1 in 12,000 Border Patrol encounters with migrants [2]—a statistic that underscores how rarely these two issues truly overlap.

Conclusion

The southern border remains a critical front in the fight against fentanyl, but the data suggests that the "open border" narrative—insofar as it implies migrants are the primary couriers—is factually incorrect. Interdicting the flow of synthetic opioids requires a surgical focus on legal ports of entry and the sophisticated networks that employ U.S. citizens as their primary agents. For policymakers, the challenge is to separate the humanitarian issues of migration from the law enforcement challenges of drug trafficking, ensuring that resources are deployed where the data says they are needed most.